Adaptive Biotechnologies (ADPT) EBITDA Margin Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) EBITDA Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 263.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -168.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 360.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -56.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -247.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 4,378.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 2,862.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 146.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 20.00 |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn | 11,567.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,567.00 |
| Dec 31, 2025 | 8,948.00 |
| Sep 30, 2025 | 10,240.00 |
| Jun 30, 2025 | 10,994.00 |
| Mar 31, 2025 | 14,573.00 |
| Dec 31, 2024 | 14,858.00 |
| Sep 30, 2024 | 11,831.00 |
| Jun 30, 2024 | 10,310.00 |
| Mar 31, 2024 | 4,008.00 |
| Dec 31, 2023 | 15,290.00 |
| Sep 30, 2023 | 6,221.00 |
| Jun 30, 2023 | -14,647.00 |
| Mar 31, 2023 | 6,702.00 |
| Dec 31, 2022 | 2,892.00 |
| Sep 30, 2022 | -2,570.00 |
| Jun 30, 2022 | -4,750.00 |
| Mar 31, 2022 | -504.00 |
| Dec 31, 2021 | -8,012.00 |
| Sep 30, 2021 | -8,942.00 |
| Jun 30, 2021 | -1,416.00 |